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Abstract: AIM: To assess the prevalence of a priori power calculations in orthodontic literature and to
identify potential associations with a number of study characteristics, including journal, year of publica-
tion and statistical significance of the outcome. MATERIALS AND METHODS: The electronic archives
of four leading orthodontic journals with the highest impact factor (American Journal of Orthodontics
and Dentofacial Orthopedics, AJODO; European Journal of Orthodontics, EJO; Angle Orthodontist,
ANGLE; Orthodontics and Craniofacial Research, OCR) were assessed over a 3 year period until De-
cember 2018. The proportion of articles reporting a priori power calculations were recorded, and the
association with journal, year of publication, study design, continent of authorship, number of centres
and researchers, statistical significance of results and reporting of confidence intervals (CIs) was assessed.
Univariable and multivariable regression were used to identify significant predictors. RESULTS: Overall,
654 eligible articles were retrieved, with the majority published in the AJODO (n = 246, 37.6%), followed
by ANGLE (n = 222, 33.9%) and EJO (n = 139, 21.3%). A total of 233 studies (35.6%) presented power
considerations a priori along with sample size calculations. Study design was a very strong predictor
with interventional design presenting 3.02 times higher odds for a priori power assumptions compared to
observational research [odds ratio (OR): 3.02; 95% CIs: 2.06, 4.42; P < 0.001]. CONCLUSIONS: Pre-
sentation of a priori power considerations for sample size calculations was not universal in contemporary
orthodontic literature, while specific study designs such as observational or animal and in vitro studies
were less likely to report such considerations.
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Aim: To assess the prevalence of a priori power calculations in orthodontic literature and to identify 
potential associations with a number of study characteristics including journal, year of publication 
and statistical significance of the outcome.     
Materials and Method: The electronic archives of four leading orthodontic journals with the 
highest impact factor (American Journal of Orthodontics and Dentofacial Orthopedics; AJODO, 
European Journal of Orthodontics; EJO, Angle Orthodontist; ANGLE, Orthodontics and Craniofacial 
Research; OCR) were assessed over a 3-year period until December 2018. The proportion of articles 
reporting a priori power calculations were recorded, and the association with journal, year of 
publication, study design, continent of authorship, number of centers and researchers, statistical 
significance of results, and reporting of confidence intervals was assessed. Univariable and 
multivariable regression were used to identify significant predictors.          
Results: Overall, 654 eligible articles were retrieved with the majority published in the AJODO 
(n=246, 37.6%), followed by ANGLE (n=222, 33.9%) and EJO (n=139, 21.3%). A total of 233 studies 
(35.6%) presented power considerations a priori along with sample size calculations. Study design 
was a very strong predictor with interventional design presenting 3.02 times higher odds for a priori 
power assumptions compared to observational research (OR: 3.02, 95% CIs: 2.06, 4.42; p<0.001). 
Conclusions: Presentation of a priori power considerations for sample size calculations was not 
universal in contemporary orthodontic literature, while specific study designs such as observational 
or animal and in-vitro studies were less likely to report such considerations.  
 




Methological and reporting flaws are prevalent among medical and dental studies, and orthodontic 
research Is not immune to pitfalls related to design, conduct and reporting (1-3). Although 
compliance with reporting guidelines has been actively endorsed by journal editors in an attempt to 
promote clinical decision-making based on correct inferences and interpretation of research 
findings (4,5),  unclear and suboptimal reporting persists (6-9). 
Sample size calculation is imperative (10) when designing a study or clinical trial and is often 
recommended in other study designs. Having inadequate participant numbers in a clinical trial is 
likely to yield inconclusive results leading to research waste, whereas including more patients than 
required may expose patients unnecessarily to ineffective or potentially harmful treatments. The 
importance of power calculations is emphasized in reporting guidelines such as the CONSORT 
statement for randomized controlled trials (11-13). The power of a study is defined as 1- beta, 
where beta is the risk of type II error (false negative) and refers to the probability of not observing a 
statistically significant difference when one actually exists. In other words, study power indicates 
the probability of identifying a difference when such a difference truly exists (14). 
It has been common practice across several biomedical fields to advocate post- experiment or post- 
hoc power calculations to justify statistically non-significant findings on the basis of constraints 
concerning recruitment of manageable or convenient number of subjects (15). However, such 
practices have been associated with erroneous inferences and interpretation of research findings 
(16). Inability to pre-define the desired power of a study is likely to deter researchers from 
obtaining the optimal sample size to detect a statistically and clinically important treatment effect, 
risking research waste in terms of cost and time (17). 
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Therefore, we aimed to assess the prevalence of reporting of a priori power calculations within 
contemporary orthodontic literature and to identify the potential effect of a number of variables on 
this practice such as journal, study design or timing of publication over a 3-year period.     
Materials and methods 
The contents of 4 major orthodontic journals with the highest impact factor were electronically 
searched over a period of 3 years and until December 2018, to identify publications that could 
potentially present either a priori or post-hoc power calculations. Journals assessed included: 
American Journal of Orthodontics and Dentofacial Orthopedics (AJODO), Angle Orthodontist 
(ANGLE), European Journal of Orthodontics (EJO), and Orthodontics and Craniofacial Research 
(OCR). The entire list of original studies was considered eligible for inclusion, excluding editorials, 
case reports, cross-sectional studies, pilot studies, opinion letters and reviews. Included studies 
were classified based on their design as interventional or observational in human subjects, while 
laboratory or animal studies were also considered separately. 
Data extraction was carried out based on pre-specified standardized piloted forms and calibration 
between the two assessors (SG, DK) was undertaken on 30 articles. Inter-rater agreement between 
examiners was assessed on 20 additional papers. Whether studies included a priori or post-hoc 
power calculations was the primary outcome assessed. Additionally, a number of characteristics 
and predictor variables were examined: journal, year of publication, study design, geographic 
region denoting affiliation of the first author, number of centers (single or multi-center, based on 
affiliation details and additional details about the place of the study within the Materials and 
Methods section), number of researchers participating in the publication, whether the primary 






Descriptive statistics were performed for the pre-defined variables. Cross-tabulations were 
constructed to test the association between reporting of a priori power calculations or otherwise 
and study characteristics, through chi- square tests. Univariable and multivariable logistic 
regression models were implemented to examine the effect of study characteristics including 
journal, year of publication and study design on conducting of a priori power calculations. The 
predictors were examined sequentially one at a time in the initial model and retained in the final 
multivariable model if p< 0.10. In addition, journal was considered an a priori predictor and was 
retained in the final model. The Hosmer-Lemeshow test was used to check model fit. The 
unweighted kappa statistic was used to assess inter-rater agreement on the reported power 
calculations. The predefined level of significance was set at p<0.05. All analyses were conducted 
with Stata version 15.1 (Stata Corporation, College Station, Texas, USA). 
Results 
A total of 982 articles were screened within the 3-year period, of which 654 were suitable for 
inclusion (Figure 1, Appendix 1). Inter-rater agreement yielded an unweighted kappa statistic of 
0.86 indicating almost perfect agreement between the two investigators (i.e. recording of a priori 
power considerations or otherwise). The highest percentage of the assessed articles were 
published in the AJODO (246/654, 37.6%), followed closely by ANGLE (222/654, 33.9%) and EJO 
(139/654, 21.2%). Most articles were published in the years 2016 and 2017 (n=461, 70.5%), 
originated from Asia/Other (267/654, 40.8%), consisted of multi-center efforts (424/654, 64.8%) 
and were authored by 4 to 6 researchers (n=406, 62.1%). Observational studies predominated 
(288/654, 44.0%) followed by interventional designs (205/654, 31.3%). Statistically significant 
findings for the main outcome were recorded for most of the studies (n=482, 73.7%), while 
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Confidence Intervals (CIs) for the estimated effect were only reported in 119 studies (18.2%) (Table 
1). The distribution of statistically significant outcomes or otherwise and reporting of CIs, across 
different study designs is presented in Table 2.  
Overall, almost two-thirds of the studies (421/654, 64.4%) failed to report a priori power 
considerations and either presented post-hoc power calculations (80/421, 19.0%) or nothing at all 
(341/421, 81.0%). Interventional study design was associated with increased reporting of a priori 
power considerations (119/205, 58%; p<0.001). Likewise, presence of non-significant findings for 
the outcome of interest (78/172, 45.3%; p=0.002) and reporting of CIs (57/119, 47.9%; p=0.002) 
were associated with this practice, respectively (Table 1). 
According to the multivariable regression model for the effect of article characteristics on the 
reporting of a priori power considerations, there was strong evidence that the study design was a 
significant predictor of the outcome (p-value for the overall Wald test<0.001), after adjusting for 
journal, significance of the study findings and reporting of confidence bounds (Figure 2). 
Specifically, interventional studies presented 3.02 times higher odds for a priori considerations 
compared to observational ones (OR=3.02; 95%CIs: 2.06, 4.42). On the contrary, in vitro research 
presented 55% lower odds (OR=0.45; 95%CIs: 0.24, 0.83) and animal studies 56% lower odds 
(OR=0.44; 95%CIs: 0.22, 0.89) for a priori considerations compared to observational research. 
Finally, studies with non-significant findings were associated with 55% higher odds (OR=1.49; 
95%CIs: 1.01, 2.20; p=0.04) for this practice conditional on journal,  study design and reporting of 




The findings of the present empirical study indicate that approximately two-thirds of orthodontic 
research articles fail to present a priori sample size calculations or present post hoc calculations. 
To the best of our knowledge there is no similar study regarding power considerations across 
different methodological designs in the existing orthodontic and dental literature and thus no 
direct comparisons can be attempted either with other dental specialties or as an updated report of 
the most recent evidence compared to previous knowledge on the topic. Notwithstanding this, 
there is abundant evidence on the transparency of reporting of sample size calculations in clinical 
trials within both biomedical (18,11) and dental literature (19,20). It has been claimed that 
reporting of sample size considerations is suboptimal within randomized controlled trials (RCTs) in 
orthodontics and other dental areas, with insufficient information presented to allow for sample 
size recalculations in over 50% thus precluding direct replication of such studies, risking false 
assumptions and potentially compromising the power of the RCTs (19,20). 
Articles stemming from observational or in- vitro/ animal research appeared to be more prone to 
omitting a priori power assumptions compared to interventional studies. This is in keeping with the 
existing evidence from biomedical literature (6,21) on research practices across these designs. 
Research conduct and reporting guidelines have been designed across different types of study 
designs (22,23); however, their adoption by the scientific community, including journal editors, 
reviewers and investigators, may lag behind that relating to interventional research including RCTs, 
or indeed as is associated with systematic reviews and meta-analyses of clinical trials.  
The preponderance of studies presenting post-hoc power calculations is interesting. This statistical 
practice has been criticised as being misleading and flawed (15). Estimation of high observed power 
after the completion of an experiment does not translate into stronger evidence for the detected 
effect. For studies with negative or non-significant effects, the use of post- hoc power calculations 
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fail to inform as to whether the observed estimate is a false-negative or a real one. Instead, 
measures of uncertainty such as confidence bounds have been proposed as a means of estimating 
the study power post-hoc. As the confidence interval around a point estimate is affected by the 
sample size of a study, useful information on the estimated treatment effect and its precision is 
available (24-26).     
A higher proportion of studies with a priori power estimations were found to report non-significant 
results for their primary outcome, while reporting of measures of uncertainty was also associated 
with this desired approach. These findings illustrate that correct practice and accurate conduct and 
reporting of research may well be followed across several stages of the study design and 
publication process. Selective reporting and publication of statistically significant results as a 
common practice has been associated with publication bias (27), while presentation and reporting 
of non- significant outcomes is equally important. Open and public registration of studies prior to 
commencement is considered guarantor of clear and transparent reporting. Optimal practices and 
reporting of one research parameter is likely to be associated with optimal reporting of another, 
when the same investigators are involved. Moreover, the onus on thorough peer-review processes 
to expose repeated conduct and reporting issues is clear. Adherence to the existing reporting 
guidelines seems imperative with an additional training of the scientific community and especially 
the editors and the reviewers in identifying evidence of research misconduct. 
The conclusions of this study are based on a subset of research articles from a finite number of 
journals. However, this is the first large-scale study on the assessment of power considerations, not 
only within interventional research and clinical trials, but across different and common study 
designs. Furthermore, the journals were selected based on their impact on orthodontic readership, 
while a dynamic and contemporary time span of the most recent publications was selected. As 
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such, the findings are likely to be representative of contemporary research practice within the 
specialty.          
 
CONCLUSIONS 
Based on the findings of the present meta-epidemiologic study, increased awareness of best 
practice concerning the design of orthodontic studies with a priori planned sample size calculations 
and power considerations should be encouraged. Improved adherence to reporting guidelines is 
important with researchers requiring awareness of optimal methodological and reporting 
characteristics.   
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Table 1. Frequency distribution for the reporting of a priori power calculation by article 
characteristic (n=654). 
 
Table 2. Distribution of statistically significant results and reporting of Confidence Intervals (CIs) 
across study design. 
 
Table 3. Univariable and multivariable logistic regression with Odds Ratios (ORs) and associated 
95% CIs for the effect of a range of article characteristics on reporting of a priori power calculation 
or otherwise (n=654). 
 
 
Figure 1. Flowchart of study selection. 
 
Figure 2. Predictive margins with 95%CIs for the effect of study design across journals on the 




Table 1. Frequency distribution for the reporting of a priori power calculation by article characteristic (n=654). 
 








Journal    0.22 
AJODO 162 (65.9) 84 (34.1) 246(100.0)  
ANGLE 136 (61.3) 86 (38.7)  222 (100.0)  
EJO 87 (62.6) 52 (37.4)  139 (100.0)  
OCR 36 (76.6) 11 (23.4)  47 (100.0)  
Year    0.36 
2016 146 (63.8) 83 (36.2) 229 (100.0)  
2017 157 (67.7) 75 (32.3) 232 (100.0)  
2018 118 (61.1) 75 (38.9) 193 (100.0)  
Continent    0.51 
America 119 (64.3) 66 (35.9) 185 (100.0)  
Europe 136 (67.3) 66 (32.7) 202 (100.0)  
Asia/other 166 (62.2) 101 (37.8) 267 (100.0)  
No. authors    0.35 
1- 3 76 (62.3) 46 (37.7) 122 (100.0)  
4- 6 257 (63.3) 149 (36.7) 406 (100.0)  
≥ 7 88 (69.8) 38 (30.2) 126 (100.0)  


























Single-center 141 (61.3) 89 (38.7) 230 (100.0)  
Multi-center 280 (66.0) 144 (34.0) 424 (100.0)  
Study Category    <0.001 
Observational 200 (69.4) 88 (30.6) 288 (100.0)  
Interventional 86 (42.0) 119 (58.0) 205 (100.0)  
In-vitro 72 (82.8) 15 (17.2) 87 (100.0)  
Animal 63 (85.1) 11 (14.9) 74 (100.0)  
Significance    0.002 
No 94 (54.7) 78 (45.3) 172 (100.0)  
Yes 327 (67.8) 155 (32.2) 482 (100.0)  
Reporting of CIs    0.002 
No 359 (67.1) 176 (32.9) 535 (100.0)  
Yes 62 (52.1) 57 (47.9) 119 (100.0)  
Total 421 (64.4) 233 (35.6) 654 (100.0)  
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Table 2. Distribution of statistically significant results and reporting of Confidence Intervals (CIs) across study design. 
 












Significance      0.005* 
No 68 (23.6) 68 (33.2) 26 (29.9) 10 (13.5) 172 (26.3)  
Yes 220 (76.4) 137 (66.8) 61 (70.1) 64 (86.5) 482 (73.7)  
Reporting of CIs      <0.001# 
No 234 (81.3) 151 (73.7) 80 (92.0) 70 (94.6) 535 (81.8)  
Yes 54 (18.7) 54 (26.3) 7 (8.0) 4 (5.4) 119 (18.2)  
Total 288 (100.0) 205 (100.0) 87 (100.0) 74 (100.0) 654 (100.0)  




Table 3. Univariable and multivariable logistic regression with Odds Ratios (ORs) and associated 95% Confidence Intervals (CIs) for the effect of 
a range of article characteristics on reporting of a priori power calculation or otherwise (n=654). 
Category Univariable Multivariable 
 OR 95% CI p-value* OR 95% CI p-value* 
Journal    0.23   0.13 
AJODO Reference   Reference   
ANGLE 1.22 0.84, 1.78  1.52 1.01, 2.30  
EJO 1.15 0.75, 1.78  1.32 0.83, 2.12  
OCR 0.59 0.29, 1.22  0.79 0.37, 1.72  
Year   0.37    
2016 Reference      
2017 0.84 0.57, 1.24     
2018 1.12 0.75, 1.66     
Continent   0.51    
Asia/other Reference      
America 0.91 0.62, 1.35     
Europe 0.80 0.54, 1.17     
No. Authors   0.36    
1-3 Reference      
4-6 0.96 0.63, 1.46     
≥ 7 0.71 0.42, 1.21     
No. Centers   0.23    
Single center Reference      
Multi center 0.81 0.58, 1.14     
Study Category   <0.001   <0.001 
Observational  Reference   Reference   
Interventional 3.14 2.16, 4.57  3.02 2.06, 4.42  
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* Wald test for the overall association; CIs: Confidence Interval
In-vitro 0.47 0.26, 0.87  0.45 0.24, 0.83  
Animal 0.40 0.20, 0.79  0.44 0.22, 0.89  
Significance   0.002   0.04 
Yes Reference   Reference   
No 1.75 1.23, 2.50  1.49 1.01, 2.20  
Reporting of CIs      0.09 
No Reference   Reference   
























OCR: 72  
 
 
 
 
 
 
 
 
 
 
